A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/66 (2006.01) A61K 31/16 (2006.01) A61K 31/19 (2006.01) A61K 31/325 (2006.01) A61K 31/40 (2006.01) A61K 31/4025 (2006.01) A61K 31/4035 (2006.01) A61K 31/445 (2006.01)
Patent
CA 2256303
The present invention relates to the use of matrix metalloproteinase inhibitors,preferably those which display specihcity for matrix metalloproteinases-2 or 9, in the treatment or prevention of ocular angiogenesis.
Pfizer Products Inc.
Smart & Biggar
LandOfFree
The use of mmp inhibitors for the treatment of ocular... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with The use of mmp inhibitors for the treatment of ocular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The use of mmp inhibitors for the treatment of ocular... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1739764